Ocular Therapeutix, Inc. (OCUL)
7.54
+0.03
(+0.40%)
USD |
NASDAQ |
Oct 09, 16:00
7.53
-0.01
(-0.13%)
After-Hours: 20:00
Ocular Therapeutix Cash and Short Term Investments (Quarterly) : 598.64M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 598.64M |
| March 31, 2026 | 666.70M |
| December 31, 2025 | 737.06M |
| September 30, 2025 | 344.77M |
| June 30, 2025 | 391.13M |
| March 31, 2025 | 349.68M |
| December 31, 2024 | 392.10M |
| September 30, 2024 | 427.22M |
| June 30, 2024 | 459.69M |
| March 31, 2024 | 483.04M |
| December 31, 2023 | 195.96M |
| September 30, 2023 | 110.55M |
| June 30, 2023 | 66.61M |
| March 31, 2023 | 79.03M |
| December 31, 2022 | 102.30M |
| September 30, 2022 | 120.95M |
| June 30, 2022 | 134.54M |
| March 31, 2022 | 145.42M |
| December 31, 2021 | 164.16M |
| September 30, 2021 | 179.28M |
| June 30, 2021 | 191.86M |
| March 31, 2021 | 209.38M |
| December 31, 2020 | 228.06M |
| September 30, 2020 | 70.64M |
| June 30, 2020 | 84.29M |
| Date | Value |
|---|---|
| March 31, 2020 | 48.15M |
| December 31, 2019 | 54.44M |
| September 30, 2019 | 65.41M |
| June 30, 2019 | 61.76M |
| March 31, 2019 | 76.25M |
| December 31, 2018 | 54.06M |
| September 30, 2018 | 56.86M |
| June 30, 2018 | 56.83M |
| March 31, 2018 | 62.91M |
| December 31, 2017 | 41.54M |
| September 30, 2017 | 51.16M |
| June 30, 2017 | 66.05M |
| March 31, 2017 | 80.38M |
| December 31, 2016 | 68.14M |
| September 30, 2016 | 75.75M |
| June 30, 2016 | 83.89M |
| March 31, 2016 | 95.46M |
| December 31, 2015 | 105.06M |
| September 30, 2015 | 113.64M |
| June 30, 2015 | 123.78M |
| March 31, 2015 | 67.42M |
| December 31, 2014 | 74.89M |
| September 30, 2014 | 80.89M |
| June 30, 2014 | 19.94M |
| March 31, 2014 | 12.75M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| EyePoint, Inc. | 180.47M |
| ANI Pharmaceuticals, Inc. | 375.87M |
| Eli Lilly & Co. | 8.95B |
| Corcept Therapeutics, Inc. | 308.20M |
| Veru, Inc. | 25.79M |